CoChat

First evidence of the conversion of paracetamol to AM404 in human cerebrospinal fluid

Open access
Sharma, Chhaya, Long, Jamie H, Shah, Seema, Rahman, Junia, Perrett, David, Ayoub, Samir, Mehta, Vivek · 2017 · Journal of Pain Research

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index; none of the 46 sources its claims cite is checked for support yet.

Abstract

Paracetamol is arguably the most commonly used analgesic and antipyretic drug worldwide, however its mechanism of action is still not fully established. It has been shown to exert effects through multiple pathways, some actions suggested to be mediated via N-arachidonoylphenolamine (AM404). AM404, formed through conjugation of paracetamol-derived p-aminophenol with arachidonic acid in the brain, is an activator of the capsaicin receptor, TRPV1, and inhibits the reuptake of the endocannabinoid, anandamide, into postsynaptic ­neurons, as well as inhibiting synthesis of PGE 2 by COX-2. However, the presence of AM404 in the central nervous system following administration of paracetamol has not yet been demonstrated in humans. Cerebrospinal fluid (CSF) and blood were collected from 26 adult male patients between 10 and 211 minutes following intravenous administration of 1 g of paracetamol. Paracetamol was measured by high-performance liquid chromatography with UV detection. AM404 was measured by liquid chromatography-tandem mass spectrometry. AM404 was detected in 17 of the 26 evaluable CSF samples at 5–40 nmol⋅L –1 . Paracetamol was measurable in CSF within 10 minutes, with a maximum measured concentration of 60 μmol⋅L –1 at 206 minutes. This study is the first to report on the presence of AM404 in human CSF following paracetamol administration. This may represent an important finding in our understanding of paracetamol’s mechanism of action, although measured concentrations were far below the previously documented IC50 for this metabolite. Keywords: acetaminophen, paracetamol, paracetamol: mechanism of action, AM404, N-­arachidonoylphenolamine, pharmacology - theories of analgesic action

Overview

CoChat Summary

TL;DR

In 26 adult male patients undergoing spinal anesthesia, intravenous 1 g paracetamol produced detectable AM404 in human CSF for the first time, with AM404 found in 17 of 26 evaluable CSF samples. Measured AM404 concentrations were far below previously documented IC50 values, so the clinical relevance remains unclear.

Key findings

  • AM404 was detected in 17 of 26 evaluable CSF samples from 10 minutes post-administration; 14 were above the reliable quantitation limit of 5 nmol·L−1, mostly ranging 5.1–57.4 nmol·L−1, with one anomalous measurement of 166.8 nmol·L−1.
  • Paracetamol was measurable in CSF within 10 minutes at 5 μmol·L−1, with a maximal measured CSF concentration of 99 μmol·L−1; plasma paracetamol ranged from 92 to 506 μmol·L−1.
  • AM404 was detectable in only 8 of 26 plasma samples, with three above the limit of quantitation (>5 nmol·L−1), ranging 6.1–65.4 nmol·L−1.
  • Measured AM404 concentrations in CSF did not correlate with time of collection.

Methods

  • Pilot study: 30 ASA I–III adult male and female patients aged 18–80 years scheduled for elective urological surgery under spinal anesthesia were recruited; after exclusions, 26 male patients were analyzed. Patients received a single intravenous 1 g paracetamol infusion over 10 minutes and were randomized to sample collection at 15, 30, or 120 minutes post-infusion.
  • CSF (5 mL) and blood (10 mL) were collected at lumbar puncture before intrathecal local anesthetic; samples were stored on ice, centrifuged, and frozen at −20°C until analysis.
  • Paracetamol was measured by HPLC with UV detection; AM404 was measured by LC-MS/MS. The study reports measured concentrations and examined whether CSF AM404 correlated with collection time.

Limitations

  • Stated: the exact pathway and clinical relevance of AM404 in humans remain unclear; evidence for AM404 comes largely from animal studies; measured concentrations were far below the previously documented IC50 for this metabolite, and IC50/EC50 values have not been measured in human CSF.
  • Stated: CSF AM404 concentrations may significantly underestimate brain concentrations in FAAH-rich areas; the study does not report pharmacokinetic modeling; sample collection times were not precise because of operating theater schedules.
  • Evident: this is a small pilot study with only 26 male patients analyzed (only three female patients were recruited, and four patients were excluded), using a single 1 g intravenous dose and no clinical outcome measures; masking was not carried out, though the authors state clinical bias was not a concern.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.2147/jpr.s143500

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 The concentration of paracetamol in plasma and CSF over time from 26 male patients given a single intravenous dose of 1 g paracetamol. Notes: The concentration of paracetamol was measured using HPLC with a detection time of 7.05 minutes. The concentration of paracetamol in plasma steadily declined over time with concentrations ranging from 506 to 92 µmol⋅L−1. In CSF, paracetamol was detected as early as 10 minutes with concentrations ranging from 5 to 99 µmol⋅L−1. Abbreviations: CSF, cerebrospinal fluid; HPLC, high-performance liquid chromatography.
Figure 1 The concentration of paracetamol in plasma and CSF over time from 26 male patients given a single intravenous dose of 1 g paracetamol. Notes: The concentration of paracetamol was measured using HPLC with a detection time of 7.05 minutes. The concentration of paracetamol in plasma steadily declined over time with concentrations ranging from 506 to 92 µmol⋅L−1. In CSF, paracetamol was detected as early as 10 minutes with concentrations ranging from 5 to 99 µmol⋅L−1. Abbreviations: CSF, cerebrospinal fluid; HPLC, high-performance liquid chromatography.CC BY-NC · PubMed Central
Figure 2 Using LC-MS/MS techniques, AM404 was detected in the CSF of 17 out of the 26 male patients treated with a single intravenous dose of 1 g of paracetamol. Notes: In 14 patients, the AM404 concentration was above the detection limit for quantitation (5 nmol⋅L−1) with concentrations ranging from 5.1 to 57.4 nmol⋅L−1 over 10 to 206 minutes. One patient anomalously showed a very high concentration of AM404 (166.8 nmol⋅L−1 after 15 minutes of paracetamol administration). Abbreviations: AM404, N-arachidonoylphenolamine; CSF, cerebrospinal fluid; LC-MS/MS, liquid chromatography-tandem mass spectrometry.
Figure 2 Using LC-MS/MS techniques, AM404 was detected in the CSF of 17 out of the 26 male patients treated with a single intravenous dose of 1 g of paracetamol. Notes: In 14 patients, the AM404 concentration was above the detection limit for quantitation (5 nmol⋅L−1) with concentrations ranging from 5.1 to 57.4 nmol⋅L−1 over 10 to 206 minutes. One patient anomalously showed a very high concentration of AM404 (166.8 nmol⋅L−1 after 15 minutes of paracetamol administration). Abbreviations: AM404, N-arachidonoylphenolamine; CSF, cerebrospinal fluid; LC-MS/MS, liquid chromatography-tandem mass spectrometry.CC BY-NC · PubMed Central

Verification

Claims the paper makes

0 Valid · 1 Not valid · 22 Not checked · 14 Own results and interpretations

3 more claims

Create a free account to see all 37 claims and to verify the 46 references still open.

See all claims — free account
  • It may state two separate claims as one. 17
  • The quote only partly states this claim. 1
  • Borderline: one of the tests for a substantial claim is unclear. 1
  • Probably not a substantial claim. 22

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

4 of 4

Citations

Cites

Show all 23 references

Cited by

See all 53

Metadata

Authors
Sharma, C., Long, J. H., Shah, S., Rahman, J., Perrett, D., Ayoub, S., & Mehta, V.
Affiliations
  • St Bartholomew's Hospital (GB)
  • Queen Mary University of London (GB)
  • University of East London (GB)
Corresponding author
Sharma, Chhaya
Venue
Journal of Pain Research
Published
2017-11
Volume
Volume 10
Pages
2703-2709
ISSN
1178-7090 (ISSN-L)
OpenAlex
W2769311760
Cited by
51
References
23
Citations by year
2026: 3 · 2025: 5 · 2024: 4 · 2023: 8 · 2022: 6 · 2021: 7 · 2020: 7 · 2019: 5 · 2018: 6
FWCI
3.44
Type
journal article
Language
en
Open access
Locations
  • Journal of Pain Research (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • UEL Research Repository (University of East London) (acceptedVersion)
  • UEL Research Repository (University of East London) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
  • UEL Research Repository (University of East London) (submittedVersion, cc-by-nc)
Funders
American Pain Society
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
  • Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
  • Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
Keywords
paracetamol, AM404, cerebrospinal fluid, drug metabolism, 4-aminophenol, TRPV1, cyclooxygenase-2, intravenous administration

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.